Latest News

• share
• favorite_border

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests that taking GLP-1RA is not associated with an increased risk of AKI in patients receiving anti-cancer therapies. The findings will be presented at ASN Kidney Week 2024 October 23– 27.

• share
• favorite_border

A recent analysis reveals that the number of chronic kidney disease (CKD) cases in women around the globe nearly tripled in the past three decades. Also, type 2 diabetes and hypertension were the leading causes of CKD-related deaths in women. The research will be presented at ASN Kidney Week 2024 October 23– 27.

• share
• favorite_border

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2 trial revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, helps to reduce proteinuria and maintain patients’ kidney function. Investigators evaluated the molecular mechanisms underlying felzartamab’s potential efficacy in IgAN. The findings will be presented at ASN Kidney Week 2024 October 23– 27.

• share
• favorite_border

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients’ age. A recent analysis of clinical trial data reveals that the SGLT2 inhibitor canagliflozin benefited patients across all age categories. The findings will be presented at ASN Kidney Week 2024 October 23 – 27.

• share
• favorite_border

Prior efforts to identify novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have typically evaluated proteins individually, which limits their prognostic power. The National Institute of Diabetes and Digestive and Kidney Diseases’ (NIDDK’s) CKD Biomarkers Consortium of investigators recently developed and tested novel dimensions of kidney health by combining a set of 17 urine and plasma biomarkers that had been individually associated with CKD progression. The research will be presented at ASN Kidney Week 2024 October 23– 27.

• share
• favorite_border

Vanderbilt University Medical Center will name the new expansion tower for Vanderbilt University Hospital the Jim Ayers Tower in recognition of Janet and Jim Ayers’ philanthropic legacy and abiding interest in improving the health care and quality of life for Tennesseans.

• share
• favorite_border

Relaxor ferroelectrics have greatly enhanced electrical and mechanical properties that originate in the materials’ domain structure. Knowing how quickly these materials’ properties can change is critical to understanding them. However, scientists have not been able to measure how fast these materials can respond. This study measured this reaction speed using ultrafast electron diffraction at the atomic level to obtain snapshots of the evolving domain structure.

• share
• favorite_border

Cedars-Sinai Guerin Children’s has appointed highly respected pediatric physician-scientists Mustafa Khokha, MD, and Saquib Lakhani, MD, to advance knowledge and application of genome sequencing with the goal of improving screening and treatment of genetic disorders and abnormalities.

• share
• favorite_border

Researchers from the University of Washington, Seattle, or UW, and Los Alamos National Laboratory used the Summit supercomputer at the Department of Energy’s Oak Ridge National Laboratory to answer one of fission’s biggest questions: What exactly happens during the nucleus’s “neck rupture” as it splits in two?

• share
• favorite_border

Dr. David Braun, a medical oncologist at Yale Cancer Center, will be awarded the Christopher G. Wood Rising Star Award by the Kidney Cancer Association at November's International Kidney Cancer Symposium.

• share
• favorite_border

A Wayne State University School of Medicine faculty member has been awarded a total of $2.3 million by the National Institute on Aging of the National institutes of Health for two new, concurrent projects that both address questions related to Alzheimer’s disease, a progressive, age-related degenerative brain disease characterized by memory problems, impaired judgment, cognitive issues and changes in personality.

• share
• favorite_border

Vishal Gohil, Ph.D., professor in the Texas A&M College of Agriculture and Life Sciences Department of Biochemistry and Biophysics, said fear triggers the adrenal gland to release adrenaline, a hormone that targets specific organs to help you react quickly.

• share
• favorite_border

In a new study published October 25th in the Journal of the American Medical Association, Yale School of Medicine researchers set out to test whether rapidly delivered, personalized care recommendations from a dedicated "kidney action team" could improve outcomes for hospitalized patients with acute kidney injury (AKI).

• share
• favorite_border

• share
• favorite_border

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2024 October 23–27.

• share
• favorite_border

Schmidt is one of the few exceptional individuals elected to both the National Academy of Medicine and the National Academy of Engineering

• share
• favorite_border

As Halloween approaches, Johnalyn Gordon, an urban entomologist, responds to the top five questions she receives to ease fears and help celebrate our spooky spider friends.

• share
• favorite_border

In a memo from the White House yesterday, the Biden administration is urging government agencies, namely the Pentagon and other intelligence agencies, to adopt artificial intelligence. ...